CpG‐containing ODN has a limited role in the protection against Toxoplasma gondii

R Saavedra, R Leyva, EP Tenorio… - Parasite …, 2004 - Wiley Online Library
Bacterial DNA containing immunostimulatory motifs (CpG) induces the development of a
TH1 immune response. Since protection against Toxoplasma gondii is correlated with this …

Protective Effect of Vaccination with Toxoplasma Lysate Antigen and CpG as an Adjuvant against Toxoplasma gondii in Susceptible C57BL/6 Mice

M El‐Malky, L Shaohong, T Kumagai… - Microbiology and …, 2005 - Wiley Online Library
Infection with the intracellular protozoan parasite Toxoplasma gondii causes serious public
health problems to both humans and livestock and of great economic impact worldwide …

Combination of CpG-oligodeoxynucleotides with recombinant ROP2 or GRA4 proteins induces protective immunity against Toxoplasma gondii infection

VR Sánchez, MN Pitkowski, AVF Cuppari… - Experimental …, 2011 - Elsevier
Synthetic oligodeoxynucleotides containing unmethylated CpG motifs (CpG-ODN) have
been characterized as Th1-promoting immunopotentiators, an adjuvant activity desirable for …

Vaccination with Toxoplasma lysate antigen and CpG oligodeoxynucleotides: comparison of immune responses in intranasal versus intramuscular administrations

MA El-Malky, SA Al-Harthi, RT Mohamed… - Parasitology …, 2014 - Springer
Toxoplasma gondii (T. gondii) is one of the most successful intracellular protozoan parasites
on earth and highly prevalent in most warm-blooded vertebrates. There are no drugs that …

CpG DNA as a Th1-promoting adjuvant in immunization against Trypanosoma cruzi

RS Corral, PB Petray - Vaccine, 2000 - Elsevier
Th1-type immune response plays a critical role in resistance to Trypanosoma cruzi infection.
We asked whether a synthetic oligodeoxynucleotide that contains immunostimulatory CpG …

CpG oligonucleotides as adjuvant in therapeutic vaccines against parasitic infections

S Zimmermann, A Dalpke, K Heeg - International Journal of Medical …, 2008 - Elsevier
Immunostimulatory CpG DNA is recognized by cells of the innate immune system through
Toll-like receptor 9 (TLR9). Synthetic CpG oligonucleotides (CpG-ODN) belong to the most …

The use of CpG as an adjuvant to Toxoplasma gondii vaccination

JA Spencer, BF Smith, AJ Guarino, BL Blagburn… - Parasitology …, 2004 - Springer
Unmethylated CpG dinucleotides have been found to stimulate general immune responses
in mammals. CpG motifs have further been shown to be potent adjuvants when used in …

Long-Term Protective Immune Response Elicited by Vaccination with an Expression Genomic Library of Toxoplasma gondii

A Fachado, A Rodriguez, J Molina… - Infection and …, 2003 - Am Soc Microbiol
Immunization of BALB/c mice with an expression genomic library of Toxoplasma gondii
induces a Th1-type immune response, with recognition of several T. gondii proteins (21 to …

Evaluation of protective effect of multi-epitope DNA vaccine encoding six antigen segments of Toxoplasma gondii in mice

S Liu, L Shi, Y Cheng, G Fan, H Ren, Y Yuan - Parasitology research, 2009 - Springer
To investigate the vaccine potential of multi-epitope vaccines against toxoplasmosis, a multi-
epitope DNA vaccine, eukaryotic plasmid pcDNA3. 1/T-ME expressing six antigen segments …

CpG-oligodeoxynucleotides enhance porcine immunity to Toxoplasma gondii

H Kringel, JP Dubey, E Beshah, R Hecker… - Veterinary …, 2004 - Elsevier
Protection against a challenge infection with Toxoplasma gondii VEG strain oocysts was
examined in pigs after vaccination with T. gondii RH strain tachyzoites with or without a …